Investing News
Stock News
World News
Business News

Home Investing News RAD 202 receives approval to start Phase 1 therapeutic trial

RAD 202 receives approval to start Phase 1 therapeutic trial

by December 20, 2024

written by December 20, 2024

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

0 comment

0

Facebook Twitter Pinterest Email

previous post

Navigating the Indecisive SPY: What Investors Should Know

next post

Malls are using new restaurants to draw consumers as shopping centers reinvent themselves

Related Posts

Netflix secures U.S. rights to the FIFA Women’s...

December 22, 2024

Tech 5: Bitcoin Drops Below US$100,000, Micron Guidance...

December 22, 2024

Stardust Power Acquires Site, Receives Key Permit And...

December 22, 2024

CFPB sues America’s largest banks for ‘allowing fraud...

December 21, 2024

Top 5 Canadian Mining Stocks This Week: Omineca...

December 21, 2024

Top 5 Canadian Mining Stocks This Week: Omineca...

December 21, 2024

Join The Exclusive Subscription Today And Get Premium Articles For Free

Your name

Your email

Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Recent Posts

Netflix secures U.S. rights to the FIFA Women’s World Cup in 2027, 2031
Tech 5: Bitcoin Drops Below US$100,000, Micron Guidance Shakes Investors
Stardust Power Acquires Site, Receives Key Permit And Receives Approval For Major Construction To Commence
Week Ahead: NIFTY’s Behavior Against This Level To Influence Trends For The Coming Weeks
CFPB sues America’s largest banks for ‘allowing fraud to fester’ on Zelle

Copyright © 2023 DarkPoolBulls.com All Rights Reserved.

Investing News
Stock News
World News
Business News

Investing News
Stock News
World News
Business News

Copyright © 2023 DarkPoolBulls.com All Rights Reserved.